To clarify that CD46 can affect bladder cancer cell proliferation without involvement of complement and/or lymphocytes, MTT in vitro proliferation assay was first performed in HT1376 and 5637 cells (Fig. 3C). This evidence concerns the gene CD46 and urinary bladder carcinoma.